Related Experiment Video
Updated: Jul 10, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Hepatitis C in dialysis patients
M Polenakovic1, P Dzekova, A Sikole
1Macedonian Academy of Sciences and Arts, Skopje, R. Macedonia. maknefpo@mt.net.mk
Insights
Hepatitis C virus (HCV) is common in dialysis patients, increasing liver and cardiovascular disease risks. Treatment with interferon alpha is recommended before kidney transplantation to improve outcomes.
Area of Science:
- Nephrology
- Hepatology
- Infectious Diseases
Background:
- Hepatitis C virus (HCV) infection is prevalent in dialysis patients, posing significant health risks.
- Risk factors for HCV spread include blood transfusions, dialysis duration, and unit prevalence.
- Challenges in policy formulation stem from high prevalence, diagnostic limitations, and transmission uncertainties.
Purpose of the Study:
- To review the epidemiology, natural history, and management of HCV infection in dialysis patients.
- To highlight the impact of HCV on mortality and transplantation outcomes.
- To discuss current treatment strategies and their implications.
Main Methods:
- Literature review of studies on HCV in dialysis patients.
- Analysis of risk factors, clinical course, and mortality.
- Evaluation of treatment options, including interferon therapy.
Main Results:
- HCV infection is common and associated with increased mortality, primarily from liver and cardiovascular diseases.
- The clinical course is often asymptomatic with slow progression.
- Pre-transplantation treatment is crucial as HCV negatively impacts graft and patient survival.
Conclusions:
- HCV poses a significant threat to dialysis patients, affecting both survival and transplant outcomes.
- Interferon alpha is the current standard treatment, requiring careful monitoring.
- Effective management and pre-transplant treatment are essential for improving patient prognosis.
Abstract:
Hepatitis C virus (HCV) remains prevalent in dialysis patients and is an important cause of liver disease in this population. A number of risk factors have been identified for spreading the HCV infection among dialysis patients, including the number of blood transfusions, the duration of dialysis, the mode of dialysis, and the prevalence of HCV infection in the dialysis unit. Difficulties in formulating policies regarding HCV infection in dialysis units arise because of the high prevalence of HCV infection in dialysis patients, the limitations of current tests in identifying these patients, and the uncertainties regarding the modes of transmission within dialysis unit. Little is known concerning the natural history of HCV infection in patients undergoing dialysis. This is due in part to an unrecognized onset of infection, the slow progression of hepatitis C viral disease, and the fact that infected dialysis patients may not have the time to become clinically apparent because of the overall shortened life-expectancy. The clinical course of HCV infection in dialysis patients is generally asymptomatic, and the progression of the disease is apparently benign. The mortality rate of infected dialysis patients is higher than in non-infected subjects, and this is not only due to the liver disease itself but also to cardiovascular disorders. Interferon alpha (standard or pegylated) is the current treatment of HCV infection in dialysis patients, with careful patient selection together with a close follow-up of the main side effect. HCV infected dialysis patients who are candidates for renal transplantation have to be treated before transplantation, since HCV infection has a negative impact on graft and patient survival and interferon therapy remains contraindicated after transplantation because of the serious risk of graft rejection.
Related Concept Videos
Hepatitis
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Hemodialysis II: Procedure and Complications
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Hemodialysis I: Introduction